For decades, the primary treatment for malaria was chloroquine, but the parasite that causes malaria has become resistant to the drug. There's a new, effective treatment called artemisinin-based combination therapy, but production of the drug is a very expensive and time-consuming process. Jay Keasling, from the Lawrence Berkeley National Laboratory, is working on producing artemisinin inside microbes.
Link to this comment:
All Comments (0)